MindWalk Holdings Corp.

NASDAQ: HYFT · Healthcare · Biotechnology

Canadian filerHQ Victoria, BCCIK 0001715925Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 53DQ —GM —SS 68

v0.1 · 35/100 weight · pillars only

↑ Piotroski F, listing tenure · ↓ return on equity, return on assets

Methodology →

Revenue TTM

$13.1M

Rev growth YoY (TTM)

+2.1%

Net income (FY)

-$21.7M

Employees

102

Market cap

$73.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$21.7M-30.2M CAD2025

Total assets$32.2M44.4M CAD2025

Liabilities$15.1M20.8M CAD2025

Revenue by segment

Filed disclosures · FY2025

By product

Project Revenue91%

Product Sales9%

By geography

UNITED STATES51%

Europe42%

AUSTRALIA4%

All Other Countries2%

CANADA1%

The read

MindWalk Holdings Corp. earned -$21.7M in FY2025 net income.

Peers · Healthcare

Atlantic International Corp.39D NDT Pharmaceuticals Inc.——electroCore, Inc.56C Pliant Therapeutics, Inc.49D

Key facts

CEOJennifer Lynne Bath

SectorHealthcare

IndustryBiotechnology

HeadquartersVictoria, BC

ExchangeNASDAQ: HYFT

Employees102

IPO date2002-01-07

Latest filings

6-K2026-07-06 6-K2026-07-01 6-K2026-06-12 6-K2026-06-10 6-K2026-06-02 6-K2026-05-27 6-K2026-05-18 6-K2026-03-31

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.